Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.
Telang S, Rasku MA, Clem AL, Carter K, Klarer AC, Badger WR, Milam RA, Rai SN, Pan J, Gragg H, Clem BF, McMasters KM, Miller DM, Chesney J.
BMC Cancer. 2011 Dec 13;11:515.
Related citations
Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M, Dusseault J, Ismaïl S, Picard-Cloutier A, Siegel PM, Larose L.
BMC Cancer. 2011 Oct 12;11:443.
EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC, Weinhäusel A, Thomas S, Horsthemke B, Lohmann DR, Zeschnigk M.
BMC Cancer. 2011 Aug 26;11:380.
Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.
Martinez-Cadenas C, Bosch N, Peñas L, Flores-Couce E, Ochoa E, Munárriz J, Aracil JP, Tajahuerce M, Royo R, Lozoya R, Boldó E.
BMC Cancer. 2011 Aug 9;11:343.
Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma.
Peric B, Zagar I, Novakovic S, Zgajnar J, Hocevar M.
BMC Cancer. 2011 Aug 2;11:328.
Gβγ subunits inhibit Epac-induced melanoma cell migration.
Baljinnyam E, Umemura M, De Lorenzo MS, Xie LH, Nowycky M, Iwatsubo M, Chen S, Goydos JS, Iwatsubo K.
BMC Cancer. 2011 Jun 17;11:256. doi: 10.1186/1471-2407-11-256.
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.
Avery-Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, Talseth-Palmer BA, Rizos H, Zhang XD, Scott RJ, Hersey P.
BMC Cancer. 2011 May 27;11:203.
Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial.
Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, Hong A, Hruby G, Burmeister B, Shivalingam B, Dhillon H, Thompson JF.
BMC Cancer. 2011 Apr 17;11:142.
Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
Chi Z, Li S, Sheng X, Si L, Cui C, Han M, Guo J.
BMC Cancer. 2011 Feb 25;11:85.
Replicase-based plasmid DNA shows anti-tumor activity.
Rodriguez BL, Yu Z, Chung WG, Weiss R, Cui Z.
BMC Cancer. 2011 Mar 28;11:110.
Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.
Yang X, Ren GX, Zhang CP, Zhou GY, Hu YJ, Yang WJ, Guo W, Li J, Zhong LP.
BMC Cancer. 2010 Nov 11;10:623.
Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
Teutschbein J, Haydn JM, Samans B, Krause M, Eilers M, Schartl M, Meierjohann S.
BMC Cancer. 2010 Jul 21;10:386.
Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand JP, Courty J, Hovanessian AG, Prévost-Blondel A.
BMC Cancer. 2010 Jun 24;10:325.
Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Thangasamy T, Sittadjody S, Mitchell GC, Mendoza EE, Radhakrishnan VM, Limesand KH, Burd R.
BMC Cancer. 2010 Jun 11;10:282.
Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
Andreu-Pérez P, Hernandez-Losa J, Moliné T, Gil R, Grueso J, Pujol A, Cortés J, Avila MA, Recio JA.
BMC Cancer. 2010 Jun 8;10:265.
High-throughput miRNA profiling of human melanoma blood samples.
Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, Lenhof HP, Meese E.
BMC Cancer. 2010 Jun 7;10:262.
Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V, Adam RL, de Sá BC, Landman G, Metze K.
BMC Cancer. 2010 Jun 5;10:260.
Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density.
Emmett MS, Symonds KE, Rigby H, Cook MG, Price R, Metcalfe C, Orlando A, Bates DO.
BMC Cancer. 2010 May 17;10:208.
Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
Kim HS, Kim EK, Jun HJ, Oh SY, Park KW, Lim do H, Lee SI, Kim JH, Kim KM, Lee DH, Lee J.
BMC Cancer. 2010 Apr 28;10:167.
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
Lesinski GB, Zimmerer JM, Kreiner M, Trefry J, Bill MA, Young GS, Becknell B, Carson WE 3rd.
BMC Cancer. 2010 Apr 14;10:142.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on